# Executive Summary

NEXQ already has substantial policy infrastructure, but the current public site still contains high-risk marketing diction. The principal exposure is not policy absence; it is the gap between broad public claims and the evidence, regulatory classification, security proof, and runtime controls needed to support those claims.

## Highest-risk current claim classes

1. Quantified health metrics: TumorQ 99.98%, HeartQ 95%, HeartQ 42%, HeartQ 25%, and 6x speed claims.
2. Clinical-use wording: diagnosis, treatment planning, clinical decision support, intervention timing, patient stratification, biomarker interpretation, PACS, and care delivery.
3. Compliance wording: HIPAA/GDPR labels without deployment-specific contracts, roles, data flows, and controls.
4. Quantum/security wording: quantum encryption integrated across every product, proprietary hybrid modes, mini-hybrid-fault-tolerant pathways, and “secure” claims without a public control map.
5. Finance wording: portfolio optimization, allocation outputs, market intelligence, and investor diligence language that may imply investment advice or AI-powered financial claims.
6. Contact/intake wording: “secure” and “private” language without explicit no-PHI, no-secrets, no-emergency, and no-privilege boundaries.
7. Terms wording: public Terms page displays template/customization language and unfinished liability/venue provisions.
8. Blog/article wording: breakthrough, revolutionizing, transforming diagnosis, anti-aging therapies, and treatment optimization.

## Integrated remediation design

The package provides safer replacement copy, route-specific redlines, developer lint rules, runtime tracking guardrails, claim-evidence schemas, blocking release gates, and test plans. The intended implementation model is:

**Claim inventory → evidence classification → safer copy replacement → route risk tag → runtime guard → counsel approval → screenshot/network evidence → revalidation clock.**

## Bottom line

The revised diction avoids overpromising. It preserves the NEXQ story while moving public copy from absolute claims to evidence-bounded, research-stage, deployment-contingent, professionally reviewed, and counsel-approved wording.